Phase 1 Study of C.001 in Retinal Degeneration
Phase 1 Study of C.001 in Retinal Degeneration
Recruiting · NCT07594236 · Registry updated 2026-08-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Study of C.001 in Retinal Degeneration | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Geographic Atrophy, Stargardt disease, age-related macular degeneration, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 | 2026-08-17 | NCT07594236 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| California Institute for Regenerative Medicine (CIRM) | 36 |
| Cellio Therapeutics Inc | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Palo Alto Medical Foundation | Palo Alto | United States | 4 |
| Retina Vision Consultants | Beverly Hills | United States | 1 |
| Retinal Consultants Medical Group | Sacramento | United States | 11 |